Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode

NCT06656416 is registered in ClinicalTrials.gov with Alto Neuroscience as lead sponsor.

NCT NCT06656416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06656416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study Followed by Open-Label Treatment of ALTO-100 in Adults With Bipolar Disorder Currently Experiencing a Major Depressive Episode
Lead sponsor
Alto Neuroscience
Phase
Phase 2
Overall status
Recruiting
Start date
October 2, 2024
Completion date
October 31, 2027
Enrollment
200 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder i or ii with a major depressive episode